Pharmaceutical

Global stock market crash likely to delay biotech IPOs

Biotech IPOs were up six-fold in Q1 2024 from the previous quarter, but the current global stock market crash means a sustained rebound is in jeopardy.

Aug 7, 2024 - 04:00
Global stock market crash likely to delay biotech IPOs
Biotech IPOs were up six-fold in Q1 2024 from the previous quarter, but the current global stock market crash means a sustained rebound is in jeopardy.
Read the original article

Tags:

Previous Article

Developing high-potent APIs: The necessary steps to follow

Next Article

How SaaS platforms are breaking the mold for clinical trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

As states ban gender-affirming care, Minnesota aims to be a refuge for trans youth

As states ban gender-affirming care, Minnesota aims to ...

Mar 28, 2023

STAT+: UnitedHealth’s profit jumps as medical costs come in lower than expected

STAT+: UnitedHealth’s profit jumps as medical costs com...

Oct 14, 2023

STAT+: Pharmalittle: Biden’s NIH nominee will get a hearing; top Democrat backs bill to ban PBM spread pricing

STAT+: Pharmalittle: Biden’s NIH nominee will get a hea...

Sep 12, 2023